Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

Federal regulators are asking Novavax to complete an additional clinical trial on its Covid-19 vaccine after previously ...

Food and Drug Administration Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, despite a steady pressure campaign from ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

The state rushed to stockpile pills after President Donald Trump promoted the drug as a treatment for COVID-19. But soon state leaders were asking for a refund.

This legislative session, Louisiana state Sen. Mike Fesi has proposed a bill to make ivermectin an over-the-counter medication, basically meaning that it can be obtained without a prescription from a ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...